Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Derivation of the human induced pluripotent stem cell line MUi017-A from a patient with homozygous Hemoglobin Constant Spring.

Stem cell research - 1 Apr 2017

Wongkummool Wasinee, Maneepitasut Warun, Munkongdee Thongperm, Tong-Ngam Pirut, Tangprasittipap Amornrat, Svasti Saovaros, Kitiyanant Narisorn, Paiboonsukwong Kittiphong, Fucharoen Suthat, Tubsuwan Alisa

Abstract excerpt

Hemoglobin Constant Spring (HbCS, HBA2: c.427T>C) is a common nondeletional α-thalassemia resulting from a nucleotide substitution at the termination codon of the HBA2 gene. Homozygosity for HbCS is characterized with mild anemia, jaundice, and splenomegaly. In this study, the human induced pluripotent stem cell line MUi017-A was successfully generated from peripheral blood CD34+ hematopoietic progenitors of a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to alpha-Thalassemia
Share to Antigens, CD34

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cellular Reprogramming

Share to Embryoid Bodies

Share to Hematopoietic Stem Cells

Share to Hemoglobins, Abnormal

Share to Induced Pluripotent Stem Cells

Share to Karyotype

Source

Identifiers

PMID: 28395746
DOI: 10.1016/j.scr.2017.02.014

Genes

HBA2

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Derivation of the human induced pluripotent stem cell line MUi017-A from a patient with homozygous Hemoglobin Constant Spring.PMID 28395746Read ↗

Establishment of MUi009 - A human induced pluripotent stem cells from a 32year old male with homozygous β°-thalassemia coinherited with heterozygous α-thalassemia 2.Semantic proximity Read ↗

Generation of human induced pluripotent stem cell line (MUi033-A) from a male with homozygous for Hemoglobin E.Semantic proximity Read ↗

Generation of human induced pluripotent stem cells (CHULAi001-A) from peripheral blood mononuclear cells of a glucose-6-phosphate dehydrogenase (G6PD) deficient subject carrying the Viangchan mutation.Semantic proximity Read ↗

A generation of human induced pluripotent stem cell line (MUi031-A) from a type-3 Gaucher disease patient carrying homozygous mutation on GBA1 gene.Semantic proximity Read ↗

Genetic correction of concurrent α- and β-thalassemia patient-derived pluripotent stem cells by the CRISPR-Cas9 technology.Semantic proximity Read ↗

Generation of human induced pluripotent stem cell line (AOUMEYi001-A) from a patient affected by Congenital disorders of glycosylation (ALG8-CDG) using self-replicating RNA vector.Semantic proximity Read ↗

Establishing a human-induced pluripotent stem cell line SMUSHi005-A from a patient with hypophosphatemic vitamin D-resistant rickets carrying the PHEX c.1586-1586+1 delAG mutation.Semantic proximity Read ↗

Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders.Semantic proximity Read ↗

Generation of induced pluripotent stem cells from peripheral blood CD34 + hematopoietic progenitors of a 31 year old healthy womanSemantic proximity Read ↗

Generation of Red Blood Cells from Human Pluripotent Stem Cells—An UpdateSemantic proximity Read ↗

A molecular roadmap of definitive erythropoiesis from human induced pluripotent stem cells.Semantic proximity Read ↗

Generation of integration-free induced pluripotent stem cell (iPSC) line MURAi002-A from hemoglobin E/β-thalassemia disease patient harboring βE/β0 (CD41/42, -CTTT) compound heterozygous mutation.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.